Skip to main content
Clinical Trials/NCT03081728
NCT03081728
Completed
Not Applicable

Incidence Of Hemidiaphragmatic Paralysis With Patient Controlled Infusion Of Low Volume Of Ropivacaine After Usg Guided Low Dose Interscalene Brachial Plexus Block

Post Graduate Institute of Medical Education and Research, Chandigarh1 site in 1 country56 target enrollmentStarted: April 1, 2017Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Enrollment
56
Locations
1
Primary Endpoint
incidence of hemidiaphragmatic paralysis

Overview

Brief Summary

to put a catheter in interscalene brachial plexus USG guided and give a bolus of drug followed by 24 hours continous infusion of drug

Detailed Description

to put a catheter in interscalene brachial plexus USG guided and give a bolus of drug followed by 24 hours continous infusion of drug. To see hemidiaphragmatic paralysis by seeing diaphragmatic excursion on M mode Usg subcostal approach, to see post operative pain, patient satisfaction score, complications if any

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients aged 18-65 years and belonging to ASA grade I, II, III, undergoing either, shoulder surgery, (rotator cuff repair, acromioplasty, hemiarthroplasty, and total shoulder replacement) or surgery for proximal humerus fracture will be recruited for the study.

Exclusion Criteria

  • a) Patient refusal for interscalene block b) Severe respiratory disease (FEV1/FVC \<0.7 and FEV1 \< 80% of predicted) c) Allergy to amide local anaesthetic drugs d) Chronic opioid therapy e) Patients who cannot understand how to operate PCA and VAS

Arms & Interventions

block

Experimental

will be given block and continuous infusion with bolus 10ml of 0.5% ropivacaine followed by infusion @ 2ml/hr of 0.2% ropivacaine

Intervention: Interscalene Block with Ropivacaine Hcl 0.2% Inj Vil 10Ml (Device)

control

Experimental

IV analgesia only with diclofenac and paracetamol

Intervention: IV diclofenac and IV paracetamol (Drug)

Outcomes

Primary Outcomes

incidence of hemidiaphragmatic paralysis

Time Frame: 24 hours

incidence of hemidiaphragmatic paralysis by M mode USG to be seen

Secondary Outcomes

  • postoperative pain(24 hours)

Investigators

Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Pankaj

Junior resident, Department of Anaesthesia and Intensive Care, MD

Post Graduate Institute of Medical Education and Research, Chandigarh

Study Sites (1)

Loading locations...

Similar Trials